AHCO vs. ADUS, AMED, LHCG, OPCH, PACS, HIMS, GH, AGL, FTRE, and NHC
Should you be buying AdaptHealth stock or one of its competitors? The main competitors of AdaptHealth include Addus HomeCare (ADUS), Amedisys (AMED), LHC Group (LHCG), Option Care Health (OPCH), PACS Group (PACS), Hims & Hers Health (HIMS), Guardant Health (GH), agilon health (AGL), Fortrea (FTRE), and National HealthCare (NHC). These companies are all part of the "medical" sector.
Addus HomeCare (NASDAQ:ADUS) and AdaptHealth (NASDAQ:AHCO) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, community ranking, media sentiment, risk, profitability, earnings and institutional ownership.
Addus HomeCare received 230 more outperform votes than AdaptHealth when rated by MarketBeat users. Likewise, 67.77% of users gave Addus HomeCare an outperform vote while only 59.23% of users gave AdaptHealth an outperform vote.
95.4% of Addus HomeCare shares are held by institutional investors. Comparatively, 82.7% of AdaptHealth shares are held by institutional investors. 4.6% of Addus HomeCare shares are held by company insiders. Comparatively, 4.4% of AdaptHealth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Addus HomeCare has a beta of 1.01, meaning that its stock price is 1% more volatile than the S&P 500. Comparatively, AdaptHealth has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500.
Addus HomeCare has a net margin of 6.04% compared to Addus HomeCare's net margin of -21.45%. AdaptHealth's return on equity of 10.03% beat Addus HomeCare's return on equity.
In the previous week, AdaptHealth had 1 more articles in the media than Addus HomeCare. MarketBeat recorded 9 mentions for AdaptHealth and 8 mentions for Addus HomeCare. AdaptHealth's average media sentiment score of 0.81 beat Addus HomeCare's score of 0.76 indicating that Addus HomeCare is being referred to more favorably in the media.
Addus HomeCare currently has a consensus target price of $116.25, suggesting a potential downside of 5.89%. AdaptHealth has a consensus target price of $10.70, suggesting a potential downside of 4.63%. Given Addus HomeCare's higher possible upside, analysts clearly believe AdaptHealth is more favorable than Addus HomeCare.
Addus HomeCare has higher earnings, but lower revenue than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.
Summary
Addus HomeCare beats AdaptHealth on 14 of the 18 factors compared between the two stocks.
Get AdaptHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for AHCO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AHCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AdaptHealth Competitors List
Related Companies and Tools
